Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 113 Show results per page	View Search Criteria \| Help With Results


1.		Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Diagnostic, Tissue collection/Repository, Treatment				Active				18 to 75				Other				2005-401 NCT00327093


2.		Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic				Approved-not yet active				60 to 80				Other				PROLOG NCT00675168


3.		Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Diagnostic				Active				15 and over				Other				SP-11-0035 NCT00123760


4.		Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Active				18 to 80				Other				CTA-Control-088421 NCT00147472


5.		18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Active				19 to 90				Other				R05-0076 NCT00207298


6.		Early on-Therapy PET at First-Line Treatment in Diffuse Large B-Cell Lymphoma Stage IIB-IV

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic, Treatment				Active				18 and over				Other				NLG PET Study NCT00286832

First Published: 2/5/2007


7.		Phase III Randomized Study of Early Fludeoxglucose F 18 Positron Emission Tomography Scan-Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients With Previously Untreated Supradiaphragmatic Stage I or II Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				15 to 70				Other				EORTC-20051 GELA-H10, EUDRACT-2005-002765-37, NCT00433433

Last Modified: 6/19/2008 First Published: 2/5/2007


8.		Phase III Randomized Study of Combination Chemotherapy in Pediatric Patients With Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic, Treatment				Active				Under 18				Other				EURONET-PHL-C1 EU-20703, EUDRACT-2006-000995-33, NCT00433459, CCLG-HD-2007-10

Last Modified: 9/30/2008 First Published: 5/8/2008


9.		Phase III Randomized Study of Response-Adapted Therapy Using Fludeoxyglucose F 18-PET/CT Imaging in Patients With Newly Diagnosed Stage II-IV Hodgkin Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				CRUK-2007-006064-30 2007-006064-30, CRUK-07/146, NCT00678327

Last Modified: 12/12/2008 First Published: 12/18/2006


10.		Phase I/II Study of the Utility of Preoperative Fludeoxyglucose F 18 Positron Emission Tomography/CT Scanning and Ferumoxtran-10 MRI Scanning Prior to Primary Chemoradiotherapy in Detecting Retroperitoneal Lymph Node Metastasis in Patients With Locoregionally Advanced Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Diagnostic				Active				Over 18				NCI				ACRIN-6671 GOG-0233, NCT00416455

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute